European consortium awarded €6.5M to study psychedelic-assisted therapy

A European consortium of 19 partners has been awarded over €6.5M by the European Union to study psilocybin to treat psychological distress in people with progressive incurable illnesses requiring palliative care.

Very successful human clinical trial with the innovative antibacterial surface-treated implants receives approval for quick end of recruitment. – Biotech Investments

EQS-News: aap Implantate AG / Key word(s): Study/Study results Very successful human clinical trial with the innovative antibacterial surface-treated implants receives approval for quick end

September 25, 2024

Nonprofit naloxone maker celebrates FDA approval by donating 200,000 doses

A nonprofit naloxone manufacturer is celebrating its recent market approval by giving away 200,000 doses of its over-the-counter nasal spray. Harm Reduction Therapeutics said in

August 9, 2023

FDA wants new trial of Actinium’s radioactive iodine drug, company to seek partner

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.